FDA Inspection 1301896 - Nexus Pharmaceuticals, LLC - June 04, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nexus Pharmaceuticals, LLC

Record Details

This FDA Inspection record concerns Nexus Pharmaceuticals, LLC, with an inspection on June 4, 2026, issued by the Chicago District Office, covering human drugs.

Company: Nexus Pharmaceuticals, LLC
Inspection Date: June 4, 2026
Product Type: Human Drugs
Office: Chicago District Office

Open in Dashboard

ID · 50e8e103-ce27-4d4c-aafe-99c6b6c73b6f

Violation Codes7

21 CFR 211.122(a)21 CFR 211.18221 CFR 211.19221 CFR 211.194(a)(2)21 CFR 211.22(a)21 CFR 211.25(a)21 CFR 211.68(b)

Full citation text and observation details available on the Dashboard.